Sober Safe Spot Returns to Mardi Gras for the Fourth Year

February 19, 2025 1:00 PM

With the arrival of 2025's Carnival season, Avenues Recovery Center is once again erecting Sober Safe Spots along the Uptown New Orleans parade route to benefit the extended recovery community.The mission of Sober Safe Spot is to strengthen and support the recovery community by creating safe, substance-free spaces at every major recreational event.For the past three years, Sober Safe Spot has served as a haven for those in recovery who wish to...

Read more

My Quest Story - Esmeralda Bonilla

February 19, 2025 12:20 PM

My mom worked for Quest Diagnostics, and she always talked about what a great company it is, so I had long waited for an opportunity to also work for Quest. I actually saw three job openings for the Logistics team, and I applied for all of them to get the opportunity to work for this company. When I filled out the application, I felt the positive vibes because I knew this was my chance. Since joining Quest, I have learned to problem solve much...

Read more

The Centrifuge Sessions: How Gilead Sciences Is Impacting Autoimmune Disease

February 19, 2025 11:05 AM

Take a spin through the latest in Gilead's science and innovation in our new series, The Centrifuge Sessions. Today we sit down with D. Barry Crittenden, Executive Director of Clinical Development, to discuss how Gilead is helping make an impact for people living with primary biliary cholangitis (PBC), a rare autoimmune disease that affects the liver.Gilead SciencesGilead Sciences, Inc. is a research-based biopharmaceutical company that...

Read more

Miracles for Mya Hosts Second Annual Gala in March to Support Children Battling Cancer

February 19, 2025 9:10 AM

Miracles for Mya, a beacon of hope for families facing pediatric cancer, is thrilled to announce its Second Annual Miracles for Mya Gala on March 8, 2025. The event will celebrate the organization's remarkable impact, including providing over $56,000 in holiday gifts to children battling cancer in 2024. It will also raise crucial funds to continue its mission of delivering joy and support to children with cancer and their families."Building on...

Read more

CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

February 19, 2025 9:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it participated in the Virtual Investor "Top 5 for ‘25" On-Demand Conference.As part of the event, John Climaco, Chief Executive Officer of CNS Pharmaceuticals, presented the top five reasons of why he believes...

Read more

DEXIS Showcases Newest Technology at Chicago Midwinter and Lab Day Conferences

February 19, 2025 9:00 AM

The newest generation of powerful DEXIS dental imaging technology will be presented this week at the Chicago Midwinter Meeting (Booth 1608) as well as LMT Lab Day Chicago (Booth B-58). The DEXIS booths will showcase the company's ORTHOPANTOMOGRAPH™ OP 3D™ imaging systems, advancements to its intraoral sensor and scanning solutions, as well as updates to DTX Studio™ Clinic, their homebase software that unites all image types for comprehensive...

Read more

Exxel Pharma Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

February 19, 2025 9:00 AM

Exxel Pharma ("Exxel" or the "Company"), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders, today announced it participated in the Virtual Investor "Top 5 for ‘25" On-Demand Conference.As part of the event, Soren Mogelsvang, PhD, President and Chief Executive Officer of Exxel, presented the top five reasons of why he believes the investment community and industry...

Read more

Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure (SBS-IF)

February 19, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") family companies Napo Pharmaceuticals ("Napo") and Napo Therapeutics today announced that the clinical protocol for Napo's Phase 2 study to evaluate the efficacy of crofelemer, Jaguar's novel plant-based anti-secretory prescription drug, for the indication of SBS-IF in adults has received regulatory clearance from health authorities in Italy and Germany, where the trial will be conducted. The study...

Read more

CNS Pharmaceuticals Announces Reverse Stock Split

February 19, 2025 8:30 AM

HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-50 reverse split of its common stock. Beginning on February 21, 2025, the Company's common stock will continue to trade on The Nasdaq Capital Market...

Read more

Cleveland Clinic Announces the Rollout of Ambience Healthcare's AI Platform

February 19, 2025 8:00 AM

Cleveland Clinic has announced the rollout of Ambience's AI platform for documentation, clinical documentation integrity (CDI), and point of care coding. This technology aims to provide more time for personal interaction during visits and reduce the administrative workload for caregivers.Later this month, Cleveland Clinic clinicians will have access to AI documentation software that records patient appointments and generates comprehensive...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Increases 2025 Expectations to More Than $50M in Pro Forma Revenues

February 19, 2025 7:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today provided shareholders with a new investor presentation, summarizing its recently-announced binding agreement to acquire Sportstech, Germany's largest connected fitness and equipment business.The presentation highlights TRNR's growth strategy and key elements of the expected Sportstech...

Read more

CBDL Launches New Mushroom Supplement Drink & Smoothie Bar

February 19, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL) is proud to announce a groundbreaking expansion with the grand opening of its brand-new Mushroom Supplement Drink & Smoothie Bar inside The CBD Vault. This strategic addition marks a significant step forward in the company's mission to diversify its wellness offerings and capitalize on the explosive growth of the functional mushroom industry, projected to surpass $69 billion by 2028.The grand opening, set to...

Read more

NanoViricides, Inc. Has Filed its Quarterly Report

February 19, 2025 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending December 31, 2024 with the Securities and Exchange Commission (SEC) on Friday, February 14, 2025. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/1379006/000141057825000140/nnvc-20241231x10q.htm) .Company FinancialsWe reported that, as of December 31, 2024, we had cash...

Read more

Kiffik Announces Global Partnership With Duracell(R) Batteries To Power New, Innovative Health Monitoring Technology

February 19, 2025 6:00 AM

KIFFIK Biomedical and Duracell U.S. Operations, Inc. ("Duracell") have agreed to collaborate and assess the integration of long-lasting, efficient power solutions with cutting-edge biomonitoring technology. This is good news for patients and the public communities, as the partnership's goal is to enhance the precision and dependability of health monitoring systems around the globe, ultimately benefiting users in hospitals, high-performance...

Read more

Compassion Center Calls for Media Accountability Amid Ongoing DEA Cannabis Rescheduling Hearings

February 19, 2025 5:00 AM

The Glocal Cannabis Nursing Institute (GCNI) and Compassion Center, the nation's oldest federally recognized nonprofit medical cannabis clinic system, calls upon media outlets to uphold journalistic integrity and report accurately on the Drug Enforcement Administration's (DEA) ongoing hearings regarding the potential rescheduling of cannabis to a Schedule III substance under the Controlled Substances Act (CSA).Despite official confirmations that...

Read more

Compassion Center Honors Pioneering Cannabinologist Dr. David Bearman for Decades of Transformative Work in Integrative Health and Medical Cannabis, Announces Leadership Promotion Around a National Expansion

February 19, 2025 5:00 AM

Compassion Center , the oldest federally-recognized nonprofit medical cannabis clinic management system in the U.S., along with the Integrative Providers Association (IPA), the Center for Incubation & Findings Research (CIFR) and the Community-Based Clinical Cannabis Evaluation & Research Network (CBCCERN) , proudly honor Dr. David Bearman of Santa Barbara, California for his groundbreaking contributions to public health, addiction medicine, and...

Read more

Compassion Center Named a Community Partner for Psychedelic Science 2025, Ushering in a New Generation of Traditional Psychedelic-Assisted Transmutations and Clinical Research Pathways Leading Towards Total Human Wholeness

February 19, 2025 5:00 AM

Opening Doors to Transformative Programs, Strategic Partnerships and Limited Investment Opportunities, Compassion Center is sincerely honored to be named a Community Partner for Psychedelic Science 2025 (PS2025), held June 16-20th, 2025 at the Colorado Convention Center. PS2025 is the world's premier, hyper-immersive experience, counterculture and education conference on psychedelic research and innovation, presented by the Multidisciplinary...

Read more

Cantargia to Participate in Leerink Partners Global Healthcare Conference

February 19, 2025 4:20 AM

Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA) today announced that members of Cantargia's management will participate in one-on-one meetings at the Leerink Partners Global Healthcare Conference in Miami, Florida, on Tuesday and Wednesday, March 11-12, 2025.For further information, please contactDamian Marron, Interim CEOTelephone: +46 (0)46-275 62 60E-mail: [email protected] CantargiaCantargia AB (publ), reg. no....

Read more

BioNxt Solutions Unveils Accelerated 90-Day Plan: Global Patent Advancements, MS Clinical Trial, and Anti-Aging Expansion

February 19, 2025 3:05 AM

VANCOUVER, BC / ACCESS Newswire / February 19, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report on several major milestones for the next 90 days, including the registration of national-level patents, the completion of a human bioequivalence study for its lead Multiple Sclerosis (MS) treatment, and the...

Read more

Former MetroHealth CEO Dr. Airica Steed's Legacy of Ethical Leadership

February 18, 2025 8:00 PM

Leadership in healthcare is more than a title-it's a commitment to transforming lives and embracing values that bridge moral integrity, professional excellence, and community impact. This is precisely the legacy of Dr. Airica Steed, the former MetroHealth CEO whose unwavering dedication to ethical leadership has left an indelible mark on the world of medicine and the communities it serves.The Core of Ethical LeadershipAt its essence, ethical...

Read more